Navigation Links
Drug Safety Center Update: Employee Alleges Actos Maker Valued Sales Over Safety
Date:3/21/2013

Philadelphia, PA (PRWEB) March 21, 2013

The medication safety advocates at DrugRisks.com are announcing updated information on the site for patients who have taken the diabetes drug Actos. In an ongoing trial over Actos bladder cancer side effects*, a former employee recently alleged in testimony that drug maker Takeda put profit concerns over safety.

DrugRisks was created to provide those taking popular prescription drugs with the latest safety alerts, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice for current litigation.

Health experts with the FDA** and European Medicines Agency*** have warned patients that long-term use of Actos may be linked to increased risks of bladder cancer. The drug has also been banned in France and Germany****.

The maker of Actos, Takeda Pharmaceuticals, now faces Actos lawsuits from as many as 3,000 patients over bladder cancer*****. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California.

DrugRisks has added information showing the first Actos lawsuit trial in California* began this month for a man dying of bladder cancer*****. Also, a former pharmacologist for Takeda testified that company emails suggested they were more concerned with continued sales of the drug rather than the safety of patients*****.

Although trials have begun, lawyers are still helping those diagnosed with bladder cancer after taking Actos file claims. Anyone affected is urged to contact the DrugRisks Safety Center or speak with a lawyer about their legal rights as soon as possible.

Due to the specialized nature of drug injury litigation against large pharmaceutical companies, DrugRisks only recommends lawyers and law firms who have already handled Actos lawsuits.
Visit http://www.DrugRisks.com today for more information on Actos bladder cancer research, side effects and litigation news, or to speak with a lawyer.

*Cooper v. Takeda Pharmaceuticals America, Inc., CGC-12-518535, California Superior Court (Los Angeles)
**http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm
***http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/public_health_alerts/2011/07/human_pha_detail_000033.jsp&mid=WC0b01ac058001d126&source=homeMedSearch&category=human
****cbsnews.com/8301-504763_162-20070492-10391704.html
*****bloomberg.com/news/2013-03-05/takeda-put-actos-sales-ahead-of-user-safety-witness-says.html

Read the full story at http://www.prweb.com/releases/actos-lawsuit/actos-lawsuits/prweb10547940.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New ASTRO white paper recommends peer review to increase quality assurance and safety
2. Studies for approval of new drugs have insufficient patients to evaluate safety
3. d'Oliveira & Associates Releases Zimmer Knee Infographic Providing Important Safety Information on High-Flex Knees
4. New Guidelines Raise Safety Bar on Concussions
5. Report: Communications technology among tools needed to aid miner safety
6. The Healthy Facilities Institute (HFI) Forms Educational Partnership with the National Floor Safety Institute (NFSI)
7. ERs Not Doing Enough to Educate Parents on Car-Seat Safety: Study
8. Space Heater Safety Tips Can Help Prevent Burns, Fires
9. Internet searches can identify drug safety issues well ahead of public alerts
10. Emergency departments not doing enough to educate parents about car seat safety
11. Report Details Steps to Boost Patient Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... MALO, FRANCE (PRWEB) , ... January 21, 2017 , ... ... of the Indian Ocean, isolated from the rest of the world with ZANZIBAR SHOWER ... East Africa, Phytocéane used key ingredients, Virgin Coconut Oil and moisturizing vegetal coral to ...
(Date:1/21/2017)... ... January 21, 2017 , ... Northern California Medical Associates (NCMA) ... their multi-specialty medical group. The dermatology practice provides general dermatologic treatment, outpatient surgery, ... add this excellent dermatology practice to our group’s medical services,” explains NCMA CEO, ...
(Date:1/21/2017)... , ... January 21, 2017 , ... In the United ... individuals experience the freedom of recovery, they often feel shame for having struggled with ... stress disorder (PTSD). In the workshop, “Rising Strong in Life After an Eating Disorder” ...
(Date:1/20/2017)... ... ... ADA Portable Motion Trek BP 300 Lift. Built for durability, this pool lift is easy ... wheeled out of the way and stored when not in use. It is freestanding and ... from customers into specific enhancements and created a new product that is built directly on ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... bible in homes across the world. Yisrayl says this generation is a time like no ... to turn to the Bible. , Yisrayl says he does not want to sound like ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Many patients don,t ... their medication when a pharmacy just a few blocks ...  To alleviate this problem Medicationdiscountcard.com has created ... see exactly how much their medication will cost at ... Easy Medicationdiscountcard.com takes ...
(Date:1/19/2017)... Jan. 19, 2017 Accuray Incorporated (Nasdaq: ... TomoTherapy® Systems continue to set the bar for excellence ... composite overall user satisfaction rating among radiation treatment delivery ... MD Buyline Market Intelligence Briefing™. The most recent ratings ... ratings among industry peers for 11 of the past ...
(Date:1/19/2017)... , Jan. 19, 2017 ViewRay, Inc. (Nasdaq: ... federal institution supporting research in Germany ... patient treatments at the University Clinic Heidelberg as part ... The MRIdian Linac program will be headed by Medical ... heads radiation oncology at the German Cancer Research Center ...
Breaking Medicine Technology: